We are live on ! Find out more
HMC

Harvard Management Company Portfolio holdings

AUM $1.82B
1-Year Est. Return 26.23%
This Fund
S&P 500
This Quarter Est. Return
+10.01%
1 Year Est. Return
+26.23%
3 Year Est. Return
+156.3%
5 Year Est. Return
+133.98%
10 Year Est. Return
+221.37%
AUM
$1.84B
AUM Growth
+$25.2M
Cap. Flow
-$149M
Cap. Flow %
-8.09%
Top 10 Hldgs %
90.94%
Holding
34
New
10
Increased
1
Reduced
6
Closed
4

Top Buys

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$226M
2
ABCL icon
AbCellera Biologics
ABCL
+$188M
3
MSFT icon
Microsoft
MSFT
+$177M
4
PRAX icon
Praxis Precision Medicines
PRAX
+$30.8M
5
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
+$20M

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$229M
2
META icon
Meta Platforms (Facebook)
META
+$187M
3
PANW icon
Palo Alto Networks
PANW
+$157M
4
ICE icon
Intercontinental Exchange
ICE
+$116M
5
UBER icon
Uber
UBER
+$99.3M

Sector Composition

Rank Sector Weight
1 Healthcare 58.26%
2 Technology 24.36%
3 Consumer Discretionary 6.03%
4 Communication Services 6.02%
5 Financials 0.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RPRX icon
1
Royalty Pharma
RPRX
$26.1B
$735M 39.88%
14,690,780
– –
CRM icon
2
Salesforce
CRM
$134B
$206M 11.2%
+927,541
New +$226M
MSFT icon
3
Microsoft
MSFT
$2.84T
$183M 9.91%
+821,062
New +$177M
ABCL icon
4
AbCellera Biologics
ABCL
$1.62B
$165M 8.96%
+4,105,095
New +$188M
LNW
5
DELISTED
Light & Wonder
LNW
$111M 6.03%
2,678,571
– –
META icon
6
Meta Platforms (Facebook)
META
$1.51T
$111M 6.02%
406,540
-681,093
-63% -$187M
PANW icon
7
Palo Alto Networks
PANW
$264B
$59.4M 3.22%
1,003,212
-3,354,114
-77% -$157M
PRAX icon
8
Praxis Precision Medicines
PRAX
$9.07B
$43.6M 2.37%
+52,841
New +$30.8M
QQQ icon
9
Invesco QQQ Trust
QQQ
$455B
$35.4M 1.92%
112,765
-497
-0.4% -$146K
RVMD icon
10
Revolution Medicines
RVMD
$40.2B
$26.5M 1.44%
670,382
– –
IVV icon
11
iShares Core S&P 500 ETF
IVV
$876B
$24.3M 1.32%
64,672
– –
RLAY icon
12
Relay Therapeutics
RLAY
$4.02B
$22.5M 1.22%
541,124
– –
KNTE
13
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$19.8M 1.07%
+498,001
New +$20M
GLD icon
14
SPDR Gold Trust
GLD
$131B
$17.2M 0.93%
96,619
-22,395
-19% -$3.94M
GBIO
15
DELISTED
Generation Bio
GBIO
$14.8M 0.8%
52,146
+1,519
+3% +$488K
PLRX icon
16
Pliant Therapeutics
PLRX
$67.5M
$12.8M 0.69%
562,379
– –
NRIX icon
17
Nurix Therapeutics
NRIX
$2.43B
$10.3M 0.56%
314,762
– –
VEA icon
18
Vanguard FTSE Developed Markets ETF
VEA
$226B
$8.22M 0.45%
174,041
– –
NCNA
19
NuCana
NCNA
$5.37M
$7.54M 0.41%
336
-128
-28% -$3.08M
FULC icon
20
Fulcrum Therapeutics
FULC
$248M
$4.81M 0.26%
410,714
– –
IJR icon
21
iShares Core S&P Small-Cap ETF
IJR
$109B
$4.57M 0.25%
49,710
– –
VWO icon
22
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$4.03M 0.22%
80,360
– –
IJH icon
23
iShares Core S&P Mid-Cap ETF
IJH
$123B
$3.74M 0.2%
81,275
-11,445
-12% -$482K
MCRB icon
24
Seres Therapeutics
MCRB
$48M
$3.23M 0.18%
+6,592
New +$3.86M
FSDC
25
DELISTED
FS Development Corp. Class A Common Stock
FSDC
$2.75M 0.15%
+250,000
New +$2.58M
1
2

Similar funds

DWT
Dorsey & Whitney Trust Sioux Falls, South Dakota $1.82B AUM 19.69% 1-Year Est. Return
MCC
Money Concepts Capital Palm Beach Gardens, Florida $1.81B AUM 21.93% 1-Year Est. Return
ST
Spinnaker Trust Portland, Maine $1.81B AUM 17.83% 1-Year Est. Return
DE
Diversified Enterprises Wilmington, Delaware $1.83B AUM 16.79% 1-Year Est. Return
SI
Standard Investments New York $1.83B AUM 4.12% 1-Year Est. Return
WIC
Willis Investment Counsel Gainesville, Georgia $1.83B AUM 15.78% 1-Year Est. Return
GC
Gobi Capital San Francisco, California $1.8B AUM 7.28% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Harvard Management Company's Q4 2020 Portfolio in Review

As of Q4 2020, Harvard Management Company held 34 positions worth $1.84B, up 1.4% from $1.82B the previous quarter. Its ten largest holdings account for 91% of the portfolio.

Harvard Management Company withdrew a net $149M in Q4 2020, closing 4 positions and reducing 6 holdings. Its most notable exit was Alphabet (Google) Class A, an estimated $229M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 58% of assets, up from 40% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Harvard Management Company opened a new position in Salesforce worth $206M.

  • Harvard Management Company's largest Q4 2020 buy was Salesforce: 927,541 shares worth $206M.
  • Harvard Management Company added most to Generation Bio in Q4 2020, an estimated $488K increase.
  • Harvard Management Company's biggest Q4 2020 reduction was Meta Platforms (Facebook), cutting an estimated $187M.
  • Harvard Management Company fully exited Alphabet (Google) Class A in Q4 2020, selling an estimated $229M.
  • Harvard Management Company's ten largest holdings make up 91% of its $1.84B portfolio in Q4 2020.
  • Harvard Management Company opened 10 new positions and closed 4 in Q4 2020.
  • Harvard Management Company's portfolio value rose 1.4% quarter-over-quarter to $1.84B.

Based on Harvard Management Company's 13F filing for Q4 2020, filed 12 Feb 2021.